← All Representatives

Julia Letlow

House of Representatives · Rep · LA

Terms: from 14 April 2021 to 23 December 2022 ; from 4 January 2023 to 20 December 2024 ; since 3 January 2025

Participation in roll-call votes

97 % of the 2,801 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % April 2021 : participation 97 % (34 / 35), presence 97 % (34 / 35) 2021 May 2021 : participation 100 % (23 / 23), presence 100 % (23 / 23) June 2021 : participation 100 % (48 / 48), presence 100 % (48 / 48) July 2021 : participation 100 % (50 / 50), presence 100 % (50 / 50) August 2021 : participation 100 % (6 / 6), presence 100 % (6 / 6) September 2021 : participation 98 % (51 / 52), presence 98 % (51 / 52) October 2021 : participation 100 % (27 / 27), presence 100 % (27 / 27) November 2021 : participation 100 % (49 / 49), presence 100 % (49 / 49) December 2021 : participation 100 % (61 / 61), presence 100 % (61 / 61) January 2022 : participation 100 % (13 / 13), presence 100 % (13 / 13) 2022 February 2022 : participation 100 % (34 / 34), presence 100 % (34 / 34) March 2022 : participation 100 % (54 / 54), presence 100 % (54 / 54) April 2022 : participation 100 % (39 / 39), presence 100 % (39 / 39) May 2022 : participation 99 % (90 / 91), presence 99 % (90 / 91) June 2022 : participation 99 % (66 / 67), presence 99 % (66 / 67) July 2022 : participation 100 % (118 / 118), presence 100 % (118 / 118) August 2022 : participation 100 % (3 / 3), presence 100 % (3 / 3) September 2022 : participation 98 % (56 / 57), presence 98 % (56 / 57) November 2022 : participation 100 % (14 / 14), presence 100 % (14 / 14) December 2022 : participation 100 % (58 / 58), presence 100 % (58 / 58) January 2023 : participation 100 % (84 / 84), presence 100 % (84 / 84) 2023 February 2023 : participation 96 % (23 / 24), presence 96 % (23 / 24) March 2023 : participation 100 % (58 / 58), presence 100 % (58 / 58) April 2023 : participation 100 % (20 / 20), presence 100 % (20 / 20) May 2023 : participation 100 % (42 / 42), presence 100 % (42 / 42) June 2023 : participation 100 % (45 / 45), presence 100 % (45 / 45) July 2023 : participation 99 % (92 / 93), presence 99 % (92 / 93) September 2023 : participation 99 % (130 / 131), presence 99 % (130 / 131) October 2023 : participation 100 % (37 / 37), presence 100 % (37 / 37) November 2023 : participation 99 % (130 / 131), presence 99 % (130 / 131) December 2023 : participation 100 % (35 / 35), presence 100 % (35 / 35) January 2024 : participation 100 % (29 / 29), presence 100 % (29 / 29) 2024 February 2024 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2024 : participation 100 % (45 / 45), presence 100 % (45 / 45) April 2024 : participation 94 % (63 / 67), presence 94 % (63 / 67) May 2024 : participation 95 % (58 / 61), presence 95 % (58 / 61) June 2024 : participation 100 % (103 / 103), presence 100 % (103 / 103) July 2024 : participation 83 % (54 / 65), presence 83 % (54 / 65) September 2024 : participation 91 % (50 / 55), presence 91 % (50 / 55) November 2024 : participation 96 % (22 / 23), presence 96 % (22 / 23) December 2024 : participation 87 % (34 / 39), presence 87 % (34 / 39) January 2025 : participation 96 % (24 / 25), presence 96 % (24 / 25) 2025 February 2025 : participation 96 % (25 / 26), presence 96 % (25 / 26) March 2025 : participation 84 % (27 / 32), presence 84 % (27 / 32) April 2025 : participation 100 % (27 / 27), presence 100 % (27 / 27) May 2025 : participation 94 % (31 / 33), presence 94 % (31 / 33) June 2025 : participation 100 % (40 / 40), presence 100 % (40 / 40) July 2025 : participation 100 % (33 / 33), presence 100 % (33 / 33) September 2025 : participation 100 % (64 / 64), presence 100 % (64 / 64) November 2025 : participation 100 % (23 / 23), presence 100 % (23 / 23) December 2025 : participation 100 % (57 / 57), presence 100 % (57 / 57) January 2026 : participation 94 % (44 / 47), presence 94 % (44 / 47) 2026 February 2026 : participation 93 % (28 / 30), presence 93 % (28 / 30) March 2026 : participation 100 % (30 / 30), presence 100 % (30 / 30) April 2026 : participation 96 % (45 / 47), presence 96 % (45 / 47) May 2026 : participation 44 % (16 / 36), presence 44 % (16 / 36) June 2026 : participation 93 % (39 / 42), presence 93 % (39 / 42) July 2026 : participation 98 % (49 / 50), presence 98 % (49 / 50) August 2026 : participation 100 % (2 / 2), presence 100 % (2 / 2) September 2026 : participation 100 % (29 / 29), presence 100 % (29 / 29) November 2026 : participation 54 % (7 / 13), presence 54 % (7 / 13)

Their votes

1,474 votes

DateTextResultTheir vote
H.Res. 403: Providing for consideration of H.R. 1629,the Fairness in Orphan Drug Exclusivity Act; and H. Res. 275, condemning the horrific shootings in Atlanta, GA on March 16, 2021 ✓ Adopted Against
S. 937: COVID-19 Hate Crimes Act ✓ Adopted For
H.R. 2911: VA Transparency & Trust Act ✓ Adopted For
H.R. 1065: Pregnant Workers Fairness Act ✓ Adopted Against
H.R. 2877: Behavioral Intervention Guidelines Act of 2021 ✓ Adopted For
H.R. 2547: Comprehensive Debt Collection Improvement Act ✓ Adopted Against
MOTION — On Motion to Suspend the Rules and Pass Certain Bills ✓ Adopted For
H.Res. 380: Providing for consideration of the bill (H.R. 2547) Comprehensive Debt Collection Improvement Act; providing for consideration of the bill (H.R. 1065) Pregnant Workers Fairness Act and for other purposes ✓ Adopted Against
H.R. 1629: Fairness in Orphan Drug Exclusivity Act ✗ Rejected Against
H.R. 51: Washington, D.C. Admission Act ✓ Adopted Against
H.R. 1392: Protection of Saudi Dissidents Act ✓ Adopted For
H.R. 1573: Access to Counsel Act ✓ Adopted Against
H.R. 1333: NO BAN Act ✓ Adopted Against
MOTION — On Motion to Suspend the Rules and Pass Certain Bills and Agree to a Resolution ✓ Adopted For
H.Res. 330: Providing for consideration of the bill (H.R. 51) Washington, D.C. Admission Act; providing for consideration of the bill (H.R. 1573) Access to Counsel Act; providing for consideration of the bill (H.R. 1333) NO BAN Act; and for other purposes ✓ Adopted Against
H.Res. 130: Condemning the continued violation of rights and freedoms of the people of Hong Kong by the People’s Republic of China and the Government of the Hong Kong Special Administrative Region ✓ Adopted For
H.R. 1996: SAFE Banking Act ✓ Adopted Against
H.R. 1482: 504 Credit Risk Management Improvement Act ✓ Adopted For
H.R. 1195: Workplace Violence Prevention for Health Care and Social Service Workers Act ✓ Adopted Against
H.R. 1490: 504 Modernization and Small Manufacturer Enhancement Act ✓ Adopted For
H.R. 1487: Microloan Transparency and Accountability Act ✓ Adopted For
H.R. 1502: Microloan Improvement Act ✓ Adopted For
H.R. 1899: Ensuring Compliance Against Drug Diversion Act ✓ Adopted For
H.R. 1002: Debarment Enforcement of Bad Actor Registrants Act ✓ Adopted For
H.R. 1762: Protecting Indian Tribes from Scams Act ✓ Adopted For
H.R. 446: Protecting Seniors from Emergency Scams Act ✓ Adopted Absent
H.R. 941: TRANSPLANT Act ✓ Adopted For
H.R. 7: Paycheck Fairness Act ✓ Adopted Against
H.R. 1460: Nicholas and Zachary Burt Memorial Carbon Monoxide Poisoning Prevention Act ✓ Adopted For
H.R. 1215: Fraud and Scam Reduction Act ✓ Adopted For
H.Res. 303: Providing for consideration of H.R. 7, the Paycheck Fairness Act and H.R. 1195, the Workplace Violence Prevention for Health Care and Social Service Workers Act ✓ Adopted Against
S. 164: Advancing Education on Biosimilars Act ✓ Adopted For
S. 578: Food Allergy Safety, Treatment, Education, and Research Act ✓ Adopted For
H.R. 172: United States Anti-Doping Agency Reauthorization Act ✓ Adopted For

Rows per page: 20 40 100 200